A growing number of studies supports a bidirectional relationship between inflammation and bipolar disorders (BDs)1, 2, 3: elevated levels of inflammatory markers – such as Interleukin‐1β, soluble Interleukin‐2‐Receptor (sIL2‐R), Interleukin‐6 (IL‐6) – have been reported in patients with bipolar disorders (BDs).4 The gene discussed is IL6; the disease is Diamond-Blackfan anemia.